Elicio Therapeutics Inc
Elicio Therapeutics Inc (ELTX) Historical Volatility
ELTX 30-day historical volatility is 53%. This ranks in the 25th percentile of readings over the past year.
Read more
Tracking ELTX historical volatility helps you see how much Elicio Therapeutics Inc's stock price has actually moved over past periods, giving you a baseline to judge whether current option premiums are fair, cheap, or expensive. While implied volatility tells you what the market expects, Elicio Therapeutics Inc's HV tells you what really happened. Use our scanner to monitor ELTX 30 day historical volatility alongside longer lookback windows and spot the moments when realized and implied diverge.
Historical volatility is the annualized standard deviation of an underlying's past returns, typically measured over rolling windows like 10, 20, 30, or 60 days. The ELTX 30 day historical volatility is one of the most widely watched readings because it balances responsiveness with stability. Comparing Elicio Therapeutics Inc's HV to its implied volatility reveals the volatility risk premium — when IV sits well above HV, option sellers tend to have an edge; when HV runs hot relative to IV, buyers may be underpaying for movement.
Elicio Therapeutics, Inc., a clinical-stage biotechnology company, engages in developing a pipeline of novel immunotherapies for the treatment of cancer and other diseases. The company's lead product candidate is ELI-002, an AMP therapeutic vaccine for the treatment of KRAS-driven cancers. It is also developing ELI-004, an AMP-modified CpG adjuvant, a component of ELI-002; ELI-007, a lymph node targeted AMP-peptide vaccine for mutant BRAF-driven cancers; ELI-008, a multivalent lymph node targeted AMP-peptide vaccine for mutant TP53-expressing cancers; ELI-005, a vaccine candidate for the prevention of COVID-19; ELI-011 for the treatment of hematological cancers; and ELI-012, a mKRAS TCR T cell AMP-lifier designs to use in combination with mKRAS-targeted TCR T cell therapy against mKRAS-driven cancers.
The company is headquartered in Boston, Massachusetts.
Sizing a long premium trade, modeling a covered call, or hunting volatility arbitrage all come back to one question: how much has the stock actually moved? Our scanner puts Elicio Therapeutics Inc's historical volatility side-by-side with implied readings across every lookback window, so you can see exactly where ELTX HV is running hot, cold, or in line. Make the ELTX 30 day historical volatility — and every other window — work for your edge instead of against it.
As of September 23, 2026
As of September 23, 2026
See how volatility has moved over time
Track ELTX historical volatility, spot where IV and realized volatility diverge, and find options that are priced in your favor right now.
Start your 14-day free trial→